Showing results (461-470 of 530) with videos related to

Sort By:
Pageof 53
Arthritis Care & Research|August 9, 2013
Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general populationKatherine P Liao, Tianxi Cai, Vivian S Gainer, et al.
JAMA Network Open|April 16, 2024
Hypertension, Cardiovascular Risk Factors, and Uterine Fibroid Diagnosis in MidlifeSusanna D Mitro, Lauren A Wise, L Elaine Waetjen, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 14, 2024
Weight Reduction and Target Serum Urate Level: A Longitudinal Study of Annual Medical ExaminationSho Fukui, Masato Okada, Tomohiro Shinozaki, et al.
Seminars in Arthritis and Rheumatism|April 10, 2016
Implementation of treat-to-target in rheumatoid arthritis through a Learning Collaborative: Rationale and design of the TRACTION trialDaniel H Solomon, Sara B Lee, Agnes Zak, et al.
American Heart Journal|July 31, 2013
Rationale and design of the Cardiovascular Inflammation Reduction Trial: a test of the inflammatory hypothesis of atherothrombosisBrendan M Everett, Aruna D Pradhan, Daniel H Solomon, et al.
American Heart Journal|April 1, 2009
Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trialWilliam H Shrank, Niteesh K Choudhry, Daniel H Solomon, et al.
The American Journal of Medicine|July 31, 2017
The Risk of Major NSAID Toxicity with Celecoxib, Ibuprofen, or Naproxen: A Secondary Analysis of the PRECISION TrialDaniel H Solomon, M Elaine Husni, Peter A Libby, et al.
RMD Open|September 5, 2024
Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trialsKaren Holten, Nina Paulshus Sundlisæter, Joseph Sexton, et al.
Seminars in Arthritis and Rheumatism|March 13, 2017
Investigating methotrexate toxicity within a randomized double-blinded, placebo-controlled trial: Rationale and design of the Cardiovascular Inflammation Reduction Trial-Adverse Events (CIRT-AE) StudyJeffrey A Sparks, Medha Barbhaiya, Elizabeth W Karlson, et al.
Annals of the Rheumatic Diseases|October 14, 2011
Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohortSiri Lillegraven, Femke H M Prince, Nancy A Shadick, et al.
Pageof 53